As demand for the India-made COVID-19 vaccines gathers momentum in foreign countries, even China appears to have grudgingly accepted its South Asian neighbour’s domain expertise.

An article in the China Communist Party’s mouthpiece, Global Times, states: “Experts suggested that India’s vaccines are no less competitive than Chinese COVID-19 vaccines in both research and production capacity, considering that India has the world’s largest vaccine manufacturer and lower costs in labour and facilities.”